PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN

Pascale Willem

The Coding Genome Of HIV-Associated Plasmablastic Lymphomas In South Africa

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Leona W Ayers

Mid-Region Aids and Cancer Specimen Resource Consortium

Hodgkin lymphoma Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Marshall Hicks

Clinical Relevance of FGF19 Signaling in the Resistance to Image-guided Therapy in Hepatocellular Carcinoma

Liver and intrahepatic bile ducts

Pathology

Demetrius Albanes

Pooling Project of Prospective Studies of Diet and Cancer

Trachea, bronchus and lung Testis Stomach Prostate Pancreas Oesophagus Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Leukaemia Larynx Kidney, renal pelvis and ureter Colorectum Brain, nervous system Bladder

Ju-Seog Lee

Validation of Prognostic Markers in Advanced Hepatocellular Carcinoma and Identification of Potention Serological Prognostic Markers

Liver and intrahepatic bile ducts

Pathology

Corey Casper

Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda

Non-Hodgkin lymphoma Kaposi sarcoma Cervix uteri

Pediatric oncology or childhood cancer

Robert Stanley

Investigating the role of ARC in hematopoiesis and myeloproliferative neoplasms

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Hugh-George G Patterton

Reprogramming of the Trypanosoma brucei epigenome during human infection

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Robert W. Coombs

Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri